Hi-D Imaging

Hi-D Imaging

Cardiology & Cardiovascular Health

About Hi-D Imaging

Hi-D Imaging AG is a Swiss medical technology company specializing in AI-based cardiovascular imaging solutions and digital twin services for pre-operational planning. The company addresses the time-consuming manual work required before cardiac operations, including medical scan segmentation, multi-planar reconstruction, and anatomical measurements that traditionally suffer from up to 20% inter-observer and intra-observer variability. Their flagship product, 4TAVR, is an FDA 510(k) cleared software that provides automated, one-click solutions for structural heart intervention planning, particularly for transcatheter aortic valve replacement (TAVR) procedures. The software delivers all relevant procedure planning measurements and 3D volumes with unprecedented accuracy and speed. Beyond their imaging suite, Hi-D Imaging operates a Digital Twin Lab that creates patient-specific computational models to simulate blood flow under specified conditions. These digital twins help medical device manufacturers optimize product development timelines and costs, reducing the traditional 10+ year development cycle and expensive animal studies. The company's solutions are designed for seamless integration with no training requirements, featuring user-friendly interfaces that healthcare professionals can use within minutes. Hi-D Imaging serves cardiologists, medical device manufacturers, and researchers globally, with validated methods published in high-impact scientific journals. Their technology streamlines clinical workflows while maintaining the highest security standards and providing regular automated updates.

Mission & Story

Mission

Enhance your decisions with the power of data

Clinical Focus

Medical conditions and clinical areas addressed by Hi-D Imaging.

aortic stenosisaortic regurgitationstructural heart diseasecardiovascular disease

Who It Serves

Health SystemsCardiologistsMedical Device ManufacturersResearchers

Milestones & Awards

Recent Milestones

FDA 510(k) clearance for 4TAVR software (2024). Innosuisse Scale-Up Coaching program acceptance (2024). Innovation cheque project for next generation personalized artery models in silicone (2024).

Awards & Recognition

Selected for Innosuisse Scale-Up Coaching program (2024), Innosuisse Core Coaching program (2023), EUROSTARS project funding (2022-2024)

Key Partnerships

Texas Health ResourcesTexas Health Harris Methodist HospitalELEM Biotech SL (Spain)Swiss m4m CenterUniversity of Giessen Department of Cardiology & Angiology

Social & Media

Latest Updates

Company Details

Headquarters
Winterthur, Zurich, Switzerland

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing
Last updated Jun 30, 2026

Similar Companies in this Market

View all 64
AccurKardia

AccurKardia

AI-powered platform for cardiovascular disease detection and cardiac risk assessment.

Acorai

Acorai

AI platform for cardiovascular disease detection and cardiac risk assessment.

Aisap

Aisap

11-50 employees

AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.

AliveCor

AliveCor

AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.

Anumana AI

Anumana AI

series c · 175 employees

Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.

Artrya

Artrya

11-50 employees

Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.

Bay Labs

Bay Labs

Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.

BunkerHill Health

BunkerHill Health

Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.